NHS patients may get only generic drugs, warns AstraZeneca
The CEO of pharmaceutical giant AstraZeneca warns that NHS patients may be limited to generic medicines unless the health service increases what it pays for branded drugs, raising concerns about access to cutting-edge treatments.